Accenture Venture, an engagement and investment initiative that connects rising digital software entrepreneurs has welcomed its newest member, Good Chemistry Company, a quantum chemistry company focused on employing platforms that maximize quantum chemistry, quantum computing, and machine learning. The collaboration, together with 1Qbit, will speed up research projects in Material and Life Sciences.
We’re doubling down on the growth potential of quantum computing and uncovering new ways to navigate its potential while empowering our clients to confidently absorb and access this breakthrough technology,
Simulating chemistry in this new way leverages easily and readily accessible computers on the cloud to perform simulations that were previously intractable even on expensive, high-performance computing environments. This brings a competitive advantage to clients and can change pharmaceutical drug discovery and more.
Tom Lounibos, managing director, Accenture Ventures
QEMIST Cloud by Good Chemistry Company is a cloud-based computational chemistry platform that gives computational chemistry developers the tools needed to create chemical simulation apps and workflows leveraging the research programs of quantum chemistry, machine learning, and quantum computing methods. The cloud provides access to computational chemistry tools with unprecedented scale enabled by the power of the cloud. The platform’s engine enables computational chemistry simulations to be performed in a faster, more accurate, and scalable manner.
With our platform, we are re-imagining the way computational chemistry simulations are done. Simulating chemistry on computers will help drive faster, more accurate and more accessible materials innovation in the decades to come. With Accenture’s support and collaboration, we will be able to explore the vastness of chemical space and enable rational materials design at scale.
Arman Zaribafiyan, CEO of Good Chemistry Company
Quantum computing will have a breakthrough or revolutionary positive impact on their enterprises in the future, according to Accenture Technology Vision 2022. Accenture and Biogen have collaborated with 1QBit to speed up drug discovery by developing a proof of concept that validated a quantum-computing molecule comparison approach and developing an enterprise-ready, quantum-enabled application with transparent processes that generates molecular comparison results with deeper insights about shared traits.
By building on and extending our relationship with 1QBit to the newly formed Good Chemistry Company, we are demonstrating our ongoing commitment to accelerating quantum computing innovation. We are witnessing the emergence of a new class of scalable cloud-based technology that is stretching the boundaries of what computers can solve. We recognize the potential of arming our clients with the next generation of chemistry, material science, and structural design.
Carl Dukatz, Accenture’s global quantum computing lead
Accenture Ventures’ Project Spotlight, an engagement and investment initiative that connects rising digital software entrepreneurs with the Global 2000 to bridge strategic innovation gaps, has welcomed Good Chemistry Company as the newest member. Accenture’s domain knowledge and enterprise clients are available through Project Spotlight, which assists entrepreneurs in harnessing human creativity and delivering on the promise of their technology.
Read more about the news here.